A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Clinical trial NCT01490632 · COMPLETED

Trial details

NCT number: NCT01490632
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Skin Diseases Skin Diseases, Papulosquamous

Start date: 2011-12-01
Primary completion: 2012-12-01
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.